medigraphic.com
ISSN 1561-3046 (Electronic)

2022, Number 2

<< Back Next >>

Rev Cub Med Mil 2022; 51 (2)

Anxiety and fear of COVID-19 in adults with arterial hypertension

Jiménez-Puig E, Pérez-Leiva BD, Borges-Fernández M, Pausa-Hernández RM

Language: Spanish
References: 50
Page:
PDF size: 352.31 Kb.


ABSTRACT

Introduction: COVID-19 has produced an increase in mortality rates. One of the main risk groups is made up of people with high blood pressure.
Objective: To explore the anxiety and fear reactions to COVID-19 in adults with a diagnosis of arterial hypertension.
Methods: A quantitative, cross-sectional and descriptive design was used through questionnaires in 400 hypertensive adults. The sampling was non-probabilistic and intentional. The Coronavirus Anxiety Scale and The Fear of COVID-19 Scale were used. Processing was carried out using the SPSS-25 / Windows statistical package, based on frequency analysis. The T test was applied for independent samples and effect sizes were calculated. Pearson's correlation coefficient was used.
Results: Low levels of anxiety were found in the face of COVID-19; and moderate and low levels of fear. The anxiety and fear indexes before COVID-19 were higher in the female sex. Adults with other chronic noncommunicable diseases were those who exhibited the highest levels of fear and anxiety about COVID-19. Associations were found between fear and anxiety about COVID-19. The presence of other chronic conditions was related to manifestations of anxiety and fear in the face of COVID-19.
Conclusions: There were no clinical signs of anxiety and fear associated with COVID-19 in hypertensive patients.


REFERENCES

  1. Segura MS. Con alerta pero sin pánico. El rol de los medios durante la pandemia. Rev Fac Cienc Méd Córdoba. 2020;77(1):55-58. DOI:10.31053/1853.0605.v77.n1.280661.

  2. Xiang Y-T, Yang Y, Li W, Zhang L, Zhang Q, Cheung T. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020; 7(3):228-229. DOI: 10.1016/S2215-0366(20)30046-8

  3. Departamento de Seguridad Nacional. Coronavirus (COVID-19) - 24 de septiembre 2021. Gobierno de España; 2021. [acceso: 26/09/2021]. Disponible en: https://www.dsn.gob.es/es/actualidad/sala-prensa/coronavirus-covid-19-24-septiembre-20213.

  4. Statista. Número de casos confirmados de coronavirus a nivel mundial a fecha de 12 de septiembre de 2021, por continente. Salud e industria farmacéutica, estado de salud; 2021. [acceso: 15/09/2021]. Disponible en: Disponible en: https://es.statista.com/estadisticas/1107712/covid19-casos-confirmados-a-nivel-mundial-por-region/ 4.

  5. Ministerio de Salud Pública en Cuba. Parte de cierre del día 24 de septiembre a las 12 de la noche. Minsap; 2021. [acceso: 26/09/2021]. Disponible en: https://salud.msp.gob.cu/parte-de-cierre-del-dia-24-de-septiembre-a-las-12-de-la-noche-2/5.

  6. Li J, Huang DQ, Zou B, Yang H, Zi W, Rui F, et al. Epidemiology of COVID-19: a systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021; 93:1449-1458. DOI:10.1002/jmv.264246.

  7. Organización Mundial de la Salud. Más de 700 millones de personas con hipertensión sin tratar. OMS; 2021 [acceso: 18/09/2021]. Disponible en: https://www.who.int/es/news/item/25-08-2021-more-than-700-million-people-with-untreated-hypertension7.

  8. Bonet M, Varona P, Chang M, García R, Suárez-Medina R, Arcia N, et al. III Encuesta Nacional de factores de riesgo y actividades preventivas de enfermedades no trasmisibles. Cuba 2010-2011. La Habana: Editorial de Ciencias Médicas; 2015. [acceso: 24/04/2021]. Disponible en: Disponible en: http://www.bvscuba.sld.cu/libro/iii-encuesta-nacional-de-factores-de-riesgo-y-actividades-preventivas-de-enfermedades-no-trasmisibles-cuba-2010-2011 8.

  9. Espinosa AD. Experiencias y resultados en el Proyecto Global de Cienfuegos. Rev Cub Salud Pública. 2011; 37(Supl): 619-30. Disponible en: http://scielo.sld.cu/pdf/rcsp/v37s5/spu11511.pdf9.

  10. Benet M, Morejón AF, Espinosa AD, Landrove OO, Peraza D, Ordúñez PO. Factores de riesgo para enfermedades crónicas en Cienfuegos, Cuba 2010. Resultados preliminares de CARMEN II. Medisur. 2010 [acceso: 27/04/2021]; 8(2): 56-9. Disponible en: http://scielo.sld.cu/pdf/ms/v8n2/v8n2a1166.pdf10.

  11. López-Parrales JX, Espinoza-Lucas M, Castelo Caiza MJ. Hipertensión arterial de pacientes con COVID-19 en el Hospital General Manta. Sinapsis: La revista científica del ITSUP. 2021; 1(19): [aprox. 10 pant.]. DOI: 10.37117/s.v19i1.422

  12. Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS One. 2020; 15(8): e0238215. DOI: 10.1371/journal.pone.0238215

  13. Ministerio de Salud Pública. Hipertensión arterial: comorbilidad más frecuente asociada a la mortalidad por COVID-19 en Cuba. Minsap; 2020. [acceso: 27/04/2021]. Disponible en: https://salud.msp.gob.cu/hipertension-arterial-comorbilidad-mas-frecuente-asociada-a-la-mortalidad-por-covid-19-en-cuba/?doing_wp_cron=1632880008.298569917678833007812513.

  14. Schmitz N, Thefeld W, Kruse J. Mental disorders and hypertension: factors associated with awareness and treatment of hypertension in the general population of Germany. Psychosom Med. 2006; 68(2): 246-52. DOI: 10.1097/01.psy.0000204883.77284.6b

  15. Bonnet F, Irving K, Terra JL, Nony P, Berthezene F, Moulin P. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis. 2005; 178(2): 339-44. DOI: 10.1016/j.atherosclerosis.2004.08.035

  16. Jonas B, Lando JF. Negative affect as a prospective risk factor for hypertension. Psychosomatic Medicine. 2000; 62(2): 188-96. DOI:10.1097/00006842-200003000-00006

  17. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 2020; 17(5): 1729. DOI: 10.3390/ijerph17051729

  18. Cao W, Fang Z, Hou G, Han M, Xu X, Dong J, et al. The psychological impact of the COVID-19 epidemic on college students in China. J Psychiatr Res. 2020; 287: 112934. DOI: 10.1016/j.psychres.2020.112934

  19. Gao J, Zheng P, Jia Y, Chen H, Mao Y, Chen S, et al. Mental health problems and social media exposure during COVID-19 outbreak. PLOS One. 2020; 15(4): e0231924. DOI:10.1371/journal.pone.0231924

  20. Moghanibashi-Mansourieh A. Assessing the anxiety level of Iranian general population during COVID-19 outbreak. Asian J Psychiatr. 2020; 51: 102076. DOI: 10.1016/j.ajp.2020.102076

  21. Sensoy B, Gunes A, Ari S. Anxiety and depression levels in COVID-19 disease and their relation to hypertension. Clin Exp Hypertens. 2021; 43(3): 237-41. DOI: 10.1080/10641963.2020.1847132

  22. Sensoy B, Çamci S. The relationship between the desired blood pressure level and anxiety in hypertensive patients with COVID-19. Anatol J Cardiol. 2020 [acceso: 24/04/2021]; 24(Supl 1): [aprox. 2 pant.]. Disponible en: https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-117605422.

  23. De Paiva LEP, De Freitas RL, Abad A, Almeida J, Antonelli-Ponti M, Bastos S, et al. Psychological impacts related to stress and fear during the COVID-19 pandemic: cardiovascular diseases, diabetes and psychological disorders as risk factors. World Journal of Neuroscience. 2020; 10(4):191-205. DOI: 10.4236/wjns.2020.104019

  24. León OG, Montero I. Métodos de Investigación en Psicología y Educación. Las tradiciones cuantitativa y cualitativa. 4ta ed. México: McGraw-Hill Education; 2015.

  25. Levinson DJ. A conception of adult development. Am Psychol. 1986 [acceso: 01/04/2021]; 41(1): 3-13. Disponible en: https://ils.unc.edu/courses/2020_fall/inls558_001/adultdevelopment.pdf25.

  26. Lee SA. Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety. Death Stud. 2020; 44(77): 393-401. DOI: 10.1080/07481187.2020.1748481

  27. Broche-Pérez Y, Fernández-Castillo E, Fernández-Fleites Z, Jiménez-Puig E, Vizcaíno-Escobar A, Ferrer-Lozano D, et al. Adaptation of the Cuban version of the Coronavirus Anxiety Scale. Death Stud. 2022; 46(3): 603-7. DOI: 10.1080/07481187.2020.1855610

  28. Ahorsu DK, Lin CY, Imani V, Safari M, Griffiths MD, Pakpour AH. The fear of COVID-19 Scale: Development and initial validation. Int J Ment Health Addiction. 2020; 2020: 1-9. DOI: 10.1007/s11469-020-00270-8

  29. Field A. Discovering statistic using IBM SPSS Statistic 5ed. North America: Sage; 2018.

  30. World Medical Association. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. WMA; 2018. [acceso: 01/04/2021]. Disponible en: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/30.

  31. Molerio O, García G. Influencia del estrés y las emociones en la hipertensión arterial esencial. Rev Cubana Med. 2004 [acceso: 24/04/2021]; 43(2-3): [aprox. 8 pant.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-7523200400020000731.

  32. Tian W, Jiang W, Yao J, Nicholson C, Li R, Sigurslid H, et al. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. J Med Virol. 2020; 92: 1875-83. DOI: 10.1002/jmv.26050

  33. Çölkesen F, Kilinçel O, Sözen M, Yildiz E, Beyaz S, Çölkesen F, et al. The impact of SARS-CoV-2 transmission fear and COVID-19 pandemic on the mental health of patients with primary immunodeficiency disorders and severe asthma, and other high-risk groups. Asthma Allergy Immunol. 2021; 19: 84-91. DOI:10.21911/aai.651

  34. Bonner C, Cvejic E, Ayre J, Isautier J, Semsarian C, Nickel B, et al. The psychological impact of hypertension during COVID-19 restrictions: retrospective case-control study. JMIRx Med. 2021; 2(1): e25610. DOI:10.2196/25610

  35. Fosco MJ, Silva P, Taborda GA, Ahumada L. Asociación entre aislamiento social preventivo obligatorio por COVID-19 e hipertensión arterial grave. MEDICINA. 2020 [acceso: 06/08/2021]; 80(Supl 6): 1-5. Disponible en: https://www.medicinabuenosaires.com/indices-de-2020/volumen-80-ano-2020-s-6-indice/asociacion/35.

  36. Spruill TM, Pickering TG, Schwartz JE, Mostofsky E, Ogedegbe G, Clemow L, et al. The impact of perceived hypertension status on anxiety and the white coat effect. Ann Behav Med. 2007; 34(1):1-9. DOI: 10.1007/BF02879915

  37. Prensa Latina. Cuba reporta nuevo récord de casos con la Covid-19. Prensa Latina. Noticias; 2021, [acceso: 10/05/2021]. Disponible en: https://www.prensa-latina.cu/2021/04/20/cuba-reporta-nuevo-record-de-casos-con-la-covid-19-fotos37.

  38. Alcca T, Quispe Y. Ansiedad en mujeres y varones en tiempos de COVID-19 en la ciudad de Juliaca [Tesis de pregrado]. Lima: Universidad Peruana Unión; 2020. [acceso: 10/08/2021]. Disponible en: Disponible en: https://repositorio.upeu.edu.pe/handle/20.500.12840/3673 38.

  39. Briceño MT, Oré JP. Ansiedad por el COVID-19 y bienestar psicológico en personas adultas del distrito de Ate Vitarte [Tesis de pregrado]. Lima: Universidad de San Martín de Porres; 2021. [acceso: 12/08/2021]. Disponible en: Disponible en: https://hdl.handle.net/20.500.12727/8402 39.

  40. Oliver N, Barber X, Roomp K, Roomp K. The COVID-19 Impact survey: assessing the pulse of the COVID-19 pandemic in Spain via 24 questions. J Med Internet Res. 2020; 22(9): e21319. DOI: 10.2196/21319

  41. Abad A, Da Silva JA, De Paiva LEP, Antonelli- Ponti M, Bastos S, Mármora CHC, et al. Evaluation of fear and peritraumatic distress during COVID-19 pandemic in Brazil. Advances in Infectious Diseases. 2020; 10:184-194. DOI: 10.4236/aid.2020.103019

  42. Vicario A, Fernández R, Enders J, Alves A, Cerezo GH. Prevalencia de ansiedad y depresión en pacientes con enfermedades cardiovasculares durante la pandemia COVID-19. Rev Fed Argent Cardiol. 2020 [acceso: 04/09/2021]; 49(3): [aprox. 12 pant.]. Disponible en: https://rdu.unc.edu.ar/bitstream/handle/11086/16652/Prevalencia%20de%20ansiedad%20y%20depresi%C3%B3n%20en%20pacientes%20con%20enfermedades%20cardiovasculares%20durante%20la%20pandemia%20COVID.pdf?sequence=2&isAllowed=y42.

  43. Jiménez-Puig E, León-Ramos JC, Pausa-Hernández RM, Varela YM. Ansiedad y miedo a la COVID-19 en personas con diagnóstico positivo a la enfermedad en Majagua, Ciego de Ávila. MediCiego. 2021 [en prensa].

  44. Broche-Pérez Y, Fernández-Fleites Z, Fernández-Castillo E, Jiménez-Puig E, Ferrer-Lozano D, Vizcaíno-Escobar A, et al. Female gender and knowing a person positive for COVID-19 significantly increases fear levels in the Cuban population. Int J Ment Health. 2021; 49(3): [aprox. 9 pant.]. DOI: 10.1080/00207411.2021.1952739

  45. Broche-Pérez Y, Fernández-Fleites Z, Jiménez-Puig E, Fernández-Castillo E, Rodríguez-Martin BC. Gender and fear of COVID-19 in a Cuban population sample. Int J Ment Health Addict. 2020; 2020: 1-9. DOI: 10.1007/s11469-020-00343-8

  46. Ozamiz-Etxebarria N, Dosil-Santamaria M, Picaza-Gorrochategui M, Idoiaga-Mondragon N. Niveles de estrés, ansiedad y depresión en la primera fase del brote del COVID-19 en una muestra recogida en el norte de España. Cad Saúde Pública. 2020; 36(4): e00054020. DOI: 10.1590/0102-311X00054020

  47. Rossi A, Panzeri A, Pietrabissa G, Manzoni G, Castelnuovo G, Mannarini S. The anxiety-buffer hypothesis in the time of COVID-19: when self-esteem protects from the impact of loneliness and fear on anxiety and depression. Front Psychol. 2020; 11: 2177. DOI: 10.3389/fpsyg.2020.02177

  48. Jiménez-Puig E, Pérez-Leiva BD, González-Cruz R. Ansiedad y miedo a la COVID-19 en estudiantes pesquisadores del poblado de Falcón, Villa Clara. Medicent Electrón. 2021 [acceso: 18/12/2021]; 25(4): 621-37. Disponible en: http://www.medicentro.sld.cu/index.php/medicentro/article/view/3434/277748.

  49. Hernández J. Impacto de la COVID-19 sobre la salud mental de las personas. Medicent Electrón. 2020 [acceso: 04/04/2021]; 24(3): 578-94. Disponible en: http://medicentro.sld.cu/index.php/medicentro/article/view/3203/258849.

  50. Oficina de OPS/OMS en Cuba. COVID-19. Reporte 78. Equipo de gestión de incidentes. OPS/OMS; 2021. [acceso: 04/09/2021]. Disponible en: https://www.paho.org/es/file/93614/download?token=bHW2Vq9150.




2020     |     www.medigraphic.com